The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of neoadjuvant carboplatin/docetaxel chemotherapy in sporadic and BRCA-associated triple-negative breast cancer (TNBC).
Priyanka Sharma
No relevant relationships to disclose
Shane R. Stecklein
No relevant relationships to disclose
Bruce F. Kimler
No relevant relationships to disclose
Qamar J. Khan
No relevant relationships to disclose
Carol Sue Connor
No relevant relationships to disclose
Marilee McGinness
No relevant relationships to disclose
Joshua Mammen
No relevant relationships to disclose
Jamie Lynn Wagner
No relevant relationships to disclose
Roy A. Jensen
No relevant relationships to disclose
Andrew K. Godwin
No relevant relationships to disclose
Carol J. Fabian
No relevant relationships to disclose